People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Other Health Care, Other Technology, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Simparo, Inc. | — | Other Health Care | Seed | $3.4M | $2.4M | 2023 |
| Sawfish, Inc. | — | Other Technology | Pre-Seed | $995K | $1.4M | 2023 |
| Sawfish Medical, Inc. | — | Healthtech | Pre-Seed | $720K | $6.3M | 2023 |
| Rose Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $650K | $9.5M | 2022 |
Matthew Wotiz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Wotiz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Langloss | 4 | 7 |
| Paul Viola | 2 | 2 |
| Ira Sanders | 1 | 2 |
| James Christopher Harber | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.